Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

Edwards' SAPIEN 3 Ultra RESILIA Valve continues to deliver excellent outcomes for patients in real-world data.

Image Source: Zacks Investment Research Per a Precedence Research report, the global transcatheter aortic valve replacement ...

McKay-Dee Hospital has used a relatively new heart procedure that has saved 500-plus lives. Patients would have had to go to ...

An octogenarian has successfully undergone a transcatheter aortic valve replacement (TAVR) procedure at General Hospital, Ernakulam.

The American Heart Association said that hunters should be advised that physical exertion, colder temperatures, and the ...

NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to ...